The baseline covariates included in the first model were as follows: treatment received, PD at baseline, previous therapy, sex, BMI, hepatic tumor load, primary tumor type, tumor grade, chromogranin A levels, DM, metformin use, and insulin use. The gene discussed is INS; the disease is neoplasm.